Maytas Infra Limited, A Hyderabad-based infrastructure Development Company, has bagged a Rs 39 crore order from South West Infrastructure Private Ltd., a group company of Jindal Steel Works (JSW). 

This is Maytas Infra’s second order from Jindal Steel Works. 

The recent order involves construction of township for the employees of JSW Power Project coming up near Rathnagiri district of Maharashtra State in an area of 11,000 sq. mts. The project entails construction of 3BHK units of 18 flats, 2 BHK units of 132 flats, and 96 Hostel units. 

EPIC Energy, energy management solutions provider in domestic and international market, has informed that it has been awarded a contract to conduct Investment Grade Energy Audit for 10 government buildings in Arunachal Pradesh. 

The order has been placed by the Arunachal Pradesh Energy Development Agency. 

The scope of contract includes exploring the energy conservation option in the electrical distribution system, the lightning system, the HVAC systems, the DG sets and the Water Pumping System.

According to the sources, the contract signifies EPIC’s entry into the north eastern region of the country.

Era Financial Services India Ltd., a subsidiary company of Era Group has informed that it has signed a film conducting pact with Yash Promoters & Builders Pvt. Ltd.

Parsvnath Developers, one of India’s leading real estate developers, has informed that the company’s subsidiary Parsvnath Hotels Ltd has received 5 star category approvals from Ministry of Tourism for hotel project at Patto Plaza, Panaji. 

The project is being developed on total land area of approx 3150.20 sq ft. and expected to be operational by end of 2010.

Parsvnath Developers, one of India’s leading real estate developers, has informed that the company’s subsidiary Parsvnath Hotels Ltd has received 5 star category approvals from Ministry of Tourism for hotel project at Patto Plaza, Panaji.

The project is being developed on total land area of approx 3150.20 sq ft. and expected to be operational by end of 2010.

The FDA has given its approval to Toviaz as a cure for overactive bladders in adult patients. The drug is manufactured by Schwarz Pharma of Zwickau, Germany, and is distributed in the United States by Pfizer Inc. (NYSE:PFE) of New York. FDA has given approval for two doses of the drug – 4mg and 8 mg.

Toviaz (fesoterodine fumarate) relaxes the smooth muscle tissue of the bladder. Thus it reduces urinary frequency, the urge to urinate and sudden urinary involuntary urination. All these symptoms indicate an active bladder.